 Objectives Improved Tablet  focus on stability  focus on low costs High-End Tablet  maximum dose  controlled release G&H Meeting 1-2 October, 2002.

Slides:

Advertisements

Similar presentations

 AUTHOR- Musiba Baliruno Denis, B.pharm (MUST) SUPERVISORS ;  Prof. K.A.M. Kuria, PhD - Department of Pharmaceutics and Pharmacy Practice, University.

Advertisements

SAKATA INX SAKATA INX SAKATA INX (INDIA) LTD TECHNICAL TRAINING - OFFSET INKS & VENUE : UNITECH - I COUNTRY CLUB, GURGAON TOPIC.

Purpose To determine whether metoprolol controlled/extended release

Timothy G. Fawcett, Soorya N. Kabbekodu, Fangling Needham and Cyrus E. Crowder International Centre for Diffraction Data, Newtown Square, PA, USA Experimental.

POST MARKET SURVEILLANCE OF MEFENAMIC ACID CAPSULES AND TABLETS RETAILING IN NAIROBI, KENYA Research by : Khushali Naran Pindoria U29/35778/2010 Supervisor:

Process Analytical Technologies Subcommittee Product and Process Development: An Industry Perspective David Rudd PhD Process Technology GlaxoSmithKline.

“The Third International Workshop: Drug Development and Registration” First Moscow State Medical University and Ministry of Healthcare in Russia October.

Slide 1 of 19D.K. Mubangizi, Dar Es Salaam Sept Training Workshop for Evaluators from National Medicines Regulatory Authorities in East African Community.

Pharmaceutical Product Quality Assurance Through CMC Drug Development Process Presented by Darlene Rosario (Aradigm) 21 October 2003 Meeting of the Advisory.

MIT PHARMACEUTICAL MANUFACTURING INITIATIVE (PHARMI) PHARMACEUTICAL MANUFACTURING: NEW TECHNOLOGY OPPORTUNITIES.. G.K.Raju, Ph.D. Executive Director, Pharmaceutical.

Training Course on Managing Medicines and Pharmaceutical Supplies for Tuberculosis.

Fine Chemicals Division Human Nutrition Helping Make Products More Nutritious Nano-scale Formulations of Health Ingredients Dr. Lutz End Fine Chemicals.

Also available on our internet site    

University of Medicine and Pharmacy „Iuliu Haţieganu”, Faculty of Pharmacy Department of Pharmaceutical Technology and Biopharmaceutics, , Cluj-Napoca,

BASIC DATA SPHERE OF BUSINESS organosilicon compounds silicone resins silicone corrosion inhibitor silicone additives profesional cleaning agents De-/-Anti-Icer.

The 2080 Group Contrasting Technical Issues Facing the Pharmaceutical Industry with Changes in the Domestic Automotive Industry from 1980 to the Present.

Improved Tablet  Focus on stability  Focus on reasonable production  Focus on packaging material High-End Tablet  Vision?! Study Medication  Focus.

Beijing, 4th ALLIUM Symposium, April 2004 G&H Influence of environmental and genetic factors on the alliin content of garlic bulbs - Odile Huchette INRA,

 Objectives / Deliverables  Strategy  Ideas  First Results  Recent and Next Steps G&H Meeting th April, 2002 Leipzig, Germany WP 7 Pharmaceutics.

Bioequivalence of Locally Acting Gastrointestinal Drugs: An Overview

Excipient Composition and Performance-Related Properties of Excipients Chris Moreton, Ph.D. FinnBrit Consulting IPEC-Americas FDA Seminar, October 21,

Satish Mallya January 20-22, |1 | 2-3. Pharmaceutical Development Satish Mallya Quality Workshop, Copenhagen May 18-21, 2014 May 18-21,2014.

The Pharmaceutical Composition Methodology described in this presentation has been developed to improve controlled drug delivery through site specific.

PRODUCT SHOWING Presentation and offer for :. LCD & PLASMA CLEAN Technical cleaner for TFT, LCD and Plasma displays Demand and offer Description and technical.

Study Medication  Time schedule  Résumé Development of an improved tablet formulation  Long term stability  Reasonable production conditions  Focus.

DH 29  Development of analytical methods DH 30  Analysis of EU market products DH 33  Development of a novel tablet DH 36  Preparation of study medication.

Formulation, Characterization of Pellets of Duloxetine Hydrochloride by Extrusion and Spheronization Prof. V. R. Sinha University Institute of Pharmaceutical.

1 G&H Meeting 4-5 th October, 2001 G&H Meeting 4-5 th October, 2001 Wellesbourne, UK Wellesbourne, UK WP 7 Pharmaceutics WP 7 Pharmaceutics Objectives.

Odile Huchette, research engineer Christèle Bellamy, research technician Didier Perrin, research assistant G&H October 2002, Montpellier WP3 / cultivation,

© The Lubrizol Corporation 2014, all rights reserved Next Generation High Efficient Matting Agents for UV Coatings Royce Mathews Technical Product Manager.

Lettinga Associates Foundation TOWEF0 - Paris - October 2003 Anaerobic Treatment of Textile Dyeing Wastewater (within extra work agreed on in the last.

DEWG Meeting Summary Report to COPS 08/14/2007 Jim Galvin- Luminant Energy.

Effects of Allicin on Plants Proposal By: Wang Zhi Jian(2P229) Xu Run Huai(2P230) Nicholas Sung(2P219) Chen Bo Han(2A204)

ABOUT OUR NEW HPLC METHOD  We have identified a new compound in garlic HPLC profile, the S-allyl cystein (SAC) that has a potential therapeutic activity.

Solid dosage forms Tablets

The Scientific Method Practice Lab. Scientific Methods of Inquiry Scientific Inquiry Process: Observe Ask questions Hypothesis formation Share what is.

ESPS-2: European Stroke Prevention Study s Multicentre, randomized, double-blind, placebo-controlled trial s 6,602 patients randomized within 3 months.

Progress & Challenges in Optimizing and delivering new Paediatric products Vijay Agarwal, Macleods Pharmaceuticals.

Garlic Power Team Members Wang Zhi Jian 2P2 Xu Run Huai 2P2 Nicholas Sung 2P2 Chen Bo Han 2A2 Group:

Accuracy and Stability of Enteral Paediatric Nifedipine Doses Roshni Kankali Dr Daniel Kirby Astrid Gerrard.

Ichem Ltd. is a Polish manufacturer of food supplements and cosmetics on a contract basis.

Novel Development of IR Oxycodone HCl Tablets with Aversion ® Technology Kenneth W Sommerville MD Vice President, Clinical Research Robert Rolleri Pharm.

Creating Minimally Disruptive Formulations

- Pharmaceutical Equivalence Study

HHM 5014 NUTRACEUTICAL FORMULATION TECHNOLOGY

Introduction of Biopharmaceutics & Pharmacokinetics

Solid dosage forms Tablets

PRINCIPLES OF PHARMACEUTICAL FORMULATION AND DOSAGE FORM DESIGN:

Gastrointestinal Absorption: Role of the Dosage Form

1ST International High Level Multi-Stakeholders Meeting on Promoting Pharmaceutical Sector Investments in the East African Community (EAC) Region NAIROBI.

HHM 5014 NUTRACEUTICAL FORMULATION TECHNOLOGY

Odile Huchette, research engineer

HHM 5014 NUTRACEUTICAL FORMULATION TECHNOLOGY

International Pharmaceutical Supplier GMP’s – An Update

Quality control Lecture 1.

Pharmacodynamics of amoxicillin/clavulanic acid against Haemophilus influenzae in an in vitro kinetic model: a comparison of different dosage regimens.

also available on our internet site

RAPID RELIABLE RESULTS

Objectives… G&H Meeting February, 2003 Liverpool, UK

LPRI – R&D Pharma Madrid, 9th March, 2015.

Pharmacodynamics of amoxicillin/clavulanic acid against Haemophilus influenzae in an in vitro kinetic model: a comparison of different dosage regimens.

Quality control Lecture 1.

Prescription-only vs. over-the-counter medicines

Practical Pharmaceutical Orientation

RingCap Technology Mrs. Maria Saifee Associate Professor,

University of sulaimani

Dr. Basavaraj K. Nanjwade M. Pharm, PhD. Department of Pharmaceutics

Fenofibrate USP (Micronized, control)

© 2016 Global Market Insights, Inc. USA. All Rights Reserved Offset Ink Market Size will witness a rapid growth to 2025.

SID & GP MINPROMTORG OF RUSSIA Corporate Communication Center

Presentation transcript:

 Objectives Improved Tablet  focus on stability  focus on low costs High-End Tablet  maximum dose  controlled release G&H Meeting 1-2 October, 2002 Montpellier, France WP 7 Pharmaceutics (Lichtwer Pharma)

Improved Tablet Improved Tablet A A Comparison  Dragee (Market Standard)  300 mg Garlic powder  15 – 20 Excipients  Production time:  24 h  Film coated tablet  300 mg Garlic powder  7-8 Excipients (pre dried)  Production time:  8 h

Improved Tablet Improved Tablet Film coated tablets (FCT) vs Dragees 25°C / 60% r.h.

Improved Tablet Improved Tablet  Film coated tablets (FCT) vs Dragees 30°C / 70% r.h.

Improved Tablet Improved Tablet  Dragees produced by a water based sugar-coating process are a non suitable galenic formulation when pharmaceutical stability demands must be met  100% water vapour resistant packaging is necessary (HDPE/Glas bottles)  No kind of transparent polymer blister quality provide sufficient protection  Significant improvement in stability for film coated tablets – meeting international pharmaceutical standards!  Conclusions

High-End Tablet High-End Tablet  Laboratory experiments to gain a alliin enriched extract were successful  4-5 fold enrichment of alliin (up to 7%) without transformation to allicin by a economic single-step extraction procedure  Extract seems to be suitable for direct use for production (“crystalline like” – not sticky)  Technical production – open  Garlic powder combined with a alliin rich extract

High-End Tablet High-End Tablet  Development of a slow release matrix tablet – open  Additional development time of 9-15 months necessary (only with orientation stability data) – End of the project in Jan 2004!  Garlic powder combined with a alliin rich extract

Discussion/Suggestions Discussion/Suggestions  Use of film coated tablets for clinical trials  Should the film provide a gastric acid protection? Guarantee of allicin release in the duodenum  High-End tablets as a possible target of Lichtwer’s project activities?! – not for the human intervention study (HIS) of the project  Appointment in Leiden – discussing details of HIS?